Multifunctional CRISPR-Cas9 with engineered immunosilenced human T cell epitopes-Reference-Cited by-同舟云学术

Multifunctional CRISPR-Cas9 with engineered immunosilenced human T cell epitopes

Published:2019-04-23 Issue:1 Volume:10 Page:
ISSN:2041-1723
Container-title:Nature Communications
language:en
Short-container-title:Nat Commun

Author:

Ferdosi Shayesteh R.^ORCID,Ewaisha Radwa^ORCID,Moghadam Farzaneh^ORCID,Krishna Sri^ORCID,Park Jin G.^ORCID,Ebrahimkhani Mo R.^ORCID,Kiani Samira^ORCID,Anderson Karen S.

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry

Link

http://www.nature.com/articles/s41467-019-09693-x.pdf

Reference56 articles.

1. Cyranoski, D. Chinese scientists to pioneer first human CRISPR trial. Nature 535, 476 (2016).

2. Reardon, S. First CRISPR clinical trial gets green light from US panel. Nature 531, 160–163 (2016).

3. Cavazzana-Calvo, M. et al. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 288, 669–672 (2000).

4. Gaspar, H. B. et al. Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector. Lancet 364, 2181–2187 (2004).

5. Howe, S. J. et al. Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients. J. Clin. Invest. 118, 3143–3150 (2008).

Cited by 144 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Perspectives on synthetic protein circuits in mammalian cells;Current Opinion in Biomedical Engineering;2024-12

2. Engineered Cas9 variants bypass Keap1-mediated degradation in human cells and enhance epigenome editing efficiency;Nucleic Acids Research;2024-09-04

3. Robust genome and cell engineering via in vitro and in situ circularized RNAs;Nature Biomedical Engineering;2024-08-26

4. Exploring the potential of cell-derived vesicles for transient delivery of gene editing payloads;Advanced Drug Delivery Reviews;2024-08

5. On RNA-programmable gene modulation as a versatile set of principles targeting muscular dystrophies;Molecular Therapy;2024-08